Vascular Biogenics Ltd reports results for the quarter ended in June - Earnings Summary

Notable Labs

15/08/2022 22:17

* Vascular Biogenics Ltd  VBLT.OQ  reported a quarterly
adjusted
loss of 12 cents​​ per share for the quarter ended in June. The
mean expectation of four analysts for the quarter was for a loss
of 10 cents per share.
    * Revenue fell 66% to $64.00 thousand from a year ago;
analysts
expected $1.40 million. 
    * Vascular Biogenics Ltd's reported EPS for the quarter was
a loss
of 12 cents​.
    * The mean earnings estimate of analysts had fallen by
about 2.9%
in the last three months.​ 
    * In the last 30 days there have been no earnings estimate
revisions by analysts covering the company. 
    * Vascular Biogenics Ltd shares had fallen by 85.1% this
quarter and lost 87.8% so far this year.
    * The company reported a quarterly loss of $9.43 million.
    * Wall Street's median 12-month price target for Vascular
Biogenics Ltd is $5.00 
    * The current average analyst rating on the shares is "hold"
and
the breakdown of recommendations is no "strong buy" or "buy," 4
"hold" and no "sell" or "strong sell." 

This summary was machine generated from Refinitiv data August 15
at 09:17 p.m.  ​All figures in US dollars unless otherwise
stated. QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Jun. 30 2022      -0.10          -0.12          Missed
 Mar. 31 2022      -0.11          -0.13          Missed
 Dec. 31 2021      -0.09          -0.12          Missed
 Sep. 30 2021      -0.11          -0.09          Beat